PulmPEEPs

Join third-year PCCM fellows Jen Kodela and Ariel McKenna from UMass Chan as they tackle a complex respiratory case involving a 75-year-old woman with intricate medical challenges. They share insights on the diagnostic dilemmas surrounding PL12 antisynthetase syndrome and discuss innovative treatment strategies, including the role of rituximab. The fellows also highlight the supportive and flexible nature of their fellowship program, showcasing the collaborative learning environment that fosters medical education.

In this podcast episode, we continue our summer series reviewing landmark ARDS studies. Today, Dave and Luke discuss the PROSEVA trial (published in NEJM in 2013) which evaluated the impact of early, prolonged proning in patients with severe ARDS. Article and … Continue reading →

In this podcast episode, we continue our summer series reviewing landmark ARDS studies. Today, Dave and Luke discuss the ROSE trial (published in NEJM in 2019) which investigated use of continuous neuromuscular blockade in moderate to severe ARDS. Article and Reference … Continue reading →

In this podcast episode, we continue our summer series reviewing landmark ARDS studies. Today, Dave and Luke discuss the FACTT trial, which investigated fluid management strategies in ARDS. This was published in the NEJM in 2006. Article and Reference We’re … Continue reading →

Today, we’re going to be talking about pre-oxygenation methods for endotracheal intubation and the PREOXI Trial which is hot off the presses in the New England Journal of Medicine in June of 2024. This trial has potentially widespread, practice changing … Continue reading →

Dive into the complexities of Acute Respiratory Distress Syndrome (ARDS) as this discussion launches a summer series on landmark trials. Explore the impactful ARMA trial, which revolutionized ventilation strategies in ARDS care by comparing traditional and lower tidal volumes. Discover how participant selection and trial methodologies shape critical outcomes like mortality and vent-free days. The episode emphasizes lung-protective ventilation practices, the evolution of pulmonary care, and the implications for personalized treatment approaches.

Today we’re back with another stop on our Fellows’ Case Files journey and making our way to the University of Rochester. Tune in to hear about this fascinating case and learn some key teaching points along the way. Meet Our … Continue reading →

We’re back with our Rapid Fire Journal Club, and talking about the NEJM 2023 STELLAR Trial of Sotatercept in Pulmonary Arterial Hypertension. This is a landmark trial that is actively changing the face of PAH treatment today. Listen to hear … Continue reading →

Dr. Elisabeth Riviello, an Assistant Professor at Harvard Medical School, and Dr. Theogen Twagirumugabe, a leading Anesthesiologist from Rwanda, dive into redefining Acute Respiratory Distress Syndrome (ARDS). They discuss the limitations of previous definitions and highlight the importance of a universal ARDS definition to enhance patient care globally. The conversation also touches on challenges in oxygen saturation measurement, innovative diagnostic tools like lung ultrasound, and the role of non-invasive ventilation in ARDS management, advocating for improved practices in resource-limited settings.

Welcome to our second episode of ATS 2024 highlighting content featured through the ATS Critical Care Assembly. Today we are going to be talking about one of the Critical Care Assembly Symposiums entitled: “Care of Dying in the ICU: End … Continue reading →